Journal of Atherosclerosis and Thrombosis
Online ISSN : 1880-3873
Print ISSN : 1340-3478
ISSN-L : 1340-3478
Original Articles
Increased Serum Apolipoprotein B48 Concentration in Patients with Metabolic Syndrome
Makoto KinoshitaHirofumi OhnishiTomomi MaedaNakayuki YoshimuraYoko TakeokaDaijiro YasudaJun KusanoYamato MashimoShigeyuki SaitoKazuaki ShimamotoTamio Teramoto
Author information
JOURNAL OPEN ACCESS

2009 Volume 16 Issue 4 Pages 517-522

Details
Abstract
Aim: Postprandial hyperlipidemia is characterized by an increase of chylomicron remnants (CM-R), and is a risk factor for atherosclerosis. Apolipoprotein (apo) B48 exists exclusively in chylomicroms and CM-R, and fasting plasma levels of apo B48 may reflect high postprandial levels of chylomicrons and/or CM-R. We hypothesized that fasting apo B48 levels may be increased in metabolic syndrome.
Methods: We investigated 1,349 inhabitants (528 men and 821 women aged 62.4±12.8 y; mean±S.D.) of two towns in rural Hokkaido, who underwent health checks in 2005.
Results: The fasting apo B48 level was significantly higher in males than females (geometric mean 1.92; 95% CI 1.802.04 μg/mL, vs. 1.69; 95% CI 1.611.76 μg/mL; p< 0.001). Ln (apo B48) showed a significant positive correlation with total cholesterol and ln (triglycerides), and a negative correlation with HDL-cholesterol. The correlation between ln (apo B48) and ln (triglycerides) was strong. Apo B48 was significantly higher in men and women with than without metabolic syndrome. Regression analysis revealed that ln (apo B48) was significantly associated with age, BMI, total cholesterol, HDL cholesterol, LDL cholesterol, and ln (triglyceride).
Conclusion: Fasting apo B48 levels are raised in individuals with metabolic syndrome.
Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 継承 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-sa/4.0/deed.ja
Previous article
feedback
Top